Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Interventional Cardiology Interventional Radiology Neurology Optometry Retina Women's Health View All Courses
Course Type
Supplement Multimedia Webinar In-Person Multi-Part Collection
Search
Log In

VBS Fellows Foray 2020: Cases and Real-World Treatment Strategies – Part 2

By: Anton Orlin, MD; Will Parke, MD; Aleksandra V. Rachitskaya, MD; Camila Ventura, MD, PhD

Webinar Credits: 1

This CME-accredited program, originally planned for the 2020 VBS Annual Meeting, is now digital! Carefully selected cases will be presented by fellows from around the globe. Retina cases you would not believe! Real-world treatment strategies will be enthusiastically discussed among the esteemed panel members.

This truly unique series is designed for fellows, residents, and eye care specialists who recently entered practice and are involved in the management of patients with vitreoretinal disorders.

Expiration Date: Wednesday, June 30, 2021
Release Date: May 2020

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Discuss a wide variety of treatment approaches for both age-related macular degeneration and diabetic eye disease.
  • Develop individualized treatment plans for patients with retina disorders that use a combination of imaging, treat and extend, or treat and observe approaches.
  • Apply case study examples to real-world clinical settings.

Accreditation and Designation Statement

Provided by Evolve Medical Education

Accreditation Statement

Evolve Medical Education LLC (Evolve) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

Evolve designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

 

Course Viewing Requirements

Supported Browsers:

Internet Explorer 11 for Windows

Edge (recent versions; Chromium-based) for Windows

Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux

Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:

4GB+ RAM

Recommended internet speed 5Mbps+

Faculty and Disclosures

VIT BUCKLE SOCIETY MODERATORS:

Anton Orlin, MD

Associate Professor of Ophthalmology
Weill Cornell Medical College
New York, NY

 

D. Wilkin Parke III, MD

VitreoRetinal Surgery, PA
Co-director, Vitreoretinal Surgery Fellowship Program
Minneapolis, MN

 

Aleksandra V. Rachitskaya, MD

Assistant Professor of Ophthalmology
Cole Eye Institute, Cleveland Clinic
Cleveland, OH

 

Camila Ventura, MD, PhD

Department of Ophthalmology
Retina Specialist
Department of Research, Director
Altino Ventura Foundation (FAV)
Hope Eye Hospital
Recife, Pernambuco, Brazil

 

PANELISTS:

James C. Major Jr MD, PhD, FACS

Retina Consultants of Houston
Assistant Professor
Weill Cornell Medical College
Blanton Eye Institute
Houston Methodist Hospital
Houston, TX

 

Jeremy Wolfe, MD, MS

Associate Professor of Ophthalmology

Oakland University William Beaumont School of Medicine
Partner, Associated Retinal Consultants
Co-Director, Vitreoretinal Fellowship Program
Royal Oak, MI

 

FELLOWS

 

Sulaiman Alhumaid, MD  

Bascom Palmer Eye Institute –

Anne Bates Leach Eye Hospital

 

 

Samara Marafon, MD

University of Toronto

 

 

Nathan L. Scott, MD

Bascom Palmer Eye Institute

 

 

JD Wilgucki, MD

University of Illinois at Chicago College of Medicine

 

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflict of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Moderators

Anton Orlin, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, and Carl Zeiss Meditec.

Wilkin Parke III, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Royalties: Vortex Surgical.

Aleksandra V. Rachitskaya, MD and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, and Carl Zeiss Meditec. Speaker’s Bureau: Novartis.

Camila Ventura, MD, PhD has no financial relationships with commercial interests.

Panelists

James C. Major Jr MD, PhD, FACS has no financial relationships with commercial interests.

Jeremy Wolfe, MD, MS and/or spouse/partner has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon, Allergan, Genentech, and Novartis.  Grant/Research: Genentech, Kodiak, Novartis, and Regeneron Pharmaceuticals. Speaker’s Bureau: Allergan, Genentech, Novartis, and Regeneron Pharmaceuticals. Stock/Shareholder: Vortex Surgical.

Fellows

Sulaiman Alhumaid, MD; Samara Marafon, MD; Nathan L. Scott, MD; John Wilgucki, MD have no financial relationships with commercial interests.

The Evolve staff and planners have no financial relationships with commercial interests.

Nisha Mukherjee, MD, peer reviewer, have no financial relationships with commercial interests.

 

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Carl Zeiss Meditec, or Regeneron Pharmaceuticals.

Pretest

Video Resources

Next

Test

Instructions

Step 1 of 3

Back